SCHEMBL19981464

SCHEMBL19981464

CCOC(=O)/C=C/C(=O)Nc1ncc(-c2ccccc2C)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.56
MAPT P10636 6/20 0.56
MDM2 Q00987 1/20 0.56
HTT P42858 1/20 0.53
ALDH1A1 P00352 6/20 0.46
THRB P10828 1/20 0.46
NAMPT P43490 1/20 0.46
GSTO1 P78417 1/20 0.44
LIMK1 P53667 3/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
AURKA O14965 1/20 0.42
HPGD P15428 3/20 0.42
KDM4E B2RXH2 1/20 0.42
RAB9A P51151 2/20 0.41
NPC1 O15118 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TSHR P16473 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30271561 1.00 LMNA (0.56) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL19272762 0.86 GSTO1 (0.60) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL19974175 0.85 ALDH1A1 (0.51) LMNAMAPTALDH1A1THRBNAMPT
SCHEMBL19974176 0.85 ALDH1A1 (0.51) LMNAMAPTALDH1A1THRBNAMPT
SCHEMBL30271554 0.81 LMNA (0.55) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL19981588 0.81 LMNA (0.55) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL23647324 0.80 MAPT (0.64) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL23657121 0.75 MAPT (0.58) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL23657202 0.74 MAPT (0.57) LMNAMAPTMDM2HTTALDH1A1
SCHEMBL30271563 0.74 MAPT (0.57) LMNAMAPTMDM2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LMNA 3549/4885MAPT 2930/4885MDM2 1148/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 LMNA 3549/4885MAPT 2930/4885MDM2 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.